Reply to letter to the editor: "Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019"

Anatol J Cardiol. 2022 Feb;26(2):152. doi: 10.5152/AnatolJCardiol.2022.L2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Cardiomyopathies*
  • Humans
  • Interleukin-6
  • SARS-CoV-2

Substances

  • Interleukin-6